000 | 01022 a2200277 4500 | ||
---|---|---|---|
005 | 20250513044717.0 | ||
264 | 0 | _c19950214 | |
008 | 199502s 0 0 ger d | ||
022 | _a0043-5325 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScheithauer, W | |
245 | 0 | 0 |
_a[Possibilities and limits of cytostatic chemotherapy in pancreatic carcinoma]. _h[electronic resource] |
260 |
_bWiener klinische Wochenschrift _c1994 |
||
300 |
_a704-8 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aSurvival Rate |
773 | 0 |
_tWiener klinische Wochenschrift _gvol. 106 _gno. 22 _gp. 704-8 |
|
999 |
_c7824664 _d7824664 |